Tumor Suppressive Role of MicroRNAs in Triple Negative Breast Cancer

被引:1
|
作者
Balkrishna, Acharya [1 ]
Mittal, Rashmi [1 ]
Arya, Vedpriya [1 ]
机构
[1] Patanjali Res Inst, Patanjali Herbal Res Dept, Haridwar, India
关键词
CAFs; CSCs; EMT; miRNAs; prognosis; TME; TNBC; therapeutic; STEM-CELLS; MICROENVIRONMENT; EXPRESSION; PROMOTES; METASTASIS; RESISTANCE; PROGNOSIS; INVASION; RECEPTOR; MIR-210;
D O I
10.2174/0113816128272489231124095922
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Triple-negative breast cancers are highly aggressive, a heterogeneous form of breast cancer with a high re-occurrence rate that further lacks an efficient treatment strategy and prognostic marker. The tumor microenvironment of the disease comprises cancer-associated fibroblasts, cancer stem cells, immunological molecules, epithelial-mesenchymal transition, and a metastatic microenvironment that contributes to disease progression and metastasis to distant sites. Emerging evidence indicated that miRNA clusters would be of clinical utility as they exert an oncogenic or tumor suppressor role in TNBC. The present review article aims to highlight the therapeutic significance of miRNA in targeting the above-mentioned signaling cascades and modulating the intracellular crosstalk in the tumor microenvironment of TNBC. Prognostic implications of miRNAs to depict disease-free survival, distant metastasis-free survival, relapse-free survival, and overall survival outcome were also unveiled.
引用
收藏
页码:3357 / 3367
页数:11
相关论文
共 50 条
  • [1] Unveiling Role of MicroRNAs in Metastasizing Triple Negative Breast Cancer: From Therapeutics to Delivery
    Balkrishna, Acharya
    Mittal, Rashmi
    Arya, Vedpriya
    CURRENT DRUG TARGETS, 2023, 24 (06) : 509 - 520
  • [2] Unveiling Role of MicroRNAs as Treatment Strategy and Prognostic Markers in Triple Negative Breast Cancer
    Balkrishna, Acharya
    Mittal, Rashmi
    Arya, Vedpriya
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2020, 21 (15) : 1569 - 1575
  • [3] MicroRNAs in regulation of triple-negative breast cancer progression
    Piasecka, Dominika
    Braun, Marcin
    Kordek, Radzislaw
    Sadej, Rafal
    Romanska, Hanna
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (08) : 1401 - 1411
  • [4] New progress in the role of microRNAs in the diagnosis and prognosis of triple negative breast cancer
    Fu, Yeqin
    Yang, Qiuhui
    Yang, Hongjian
    Zhang, Xiping
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [5] Circulating microRNAs and their role in the immune response in triple-negative breast cancer
    Pina-Sanchez, Patricia
    Valdez-Salazar, Hilda-Alicia
    Ruiz-Tachiquin, Martha-Eugenia
    ONCOLOGY LETTERS, 2020, 20 (05)
  • [6] Dysregulation of microRNAs in triple-negative breast cancer
    Paszek, Sylwia
    Gablo, Natalia
    Barnas, Edyta
    Szybka, Malgorzata
    Morawiec, Jan
    Kolacinska, Agnieszka
    Zawlik, Izabela
    GINEKOLOGIA POLSKA, 2017, 88 (10) : 530 - 536
  • [7] MicroRNAs Associated with Androgen Receptor and Metastasis in Triple-Negative Breast Cancer
    Ahram, Mamoun
    Abu Alragheb, Bayan
    Abushukair, Hassan
    Bawadi, Randa
    Al-Hussaini, Maysa
    CANCERS, 2024, 16 (03)
  • [8] Identification of dysregulated microRNAs in triple-negative breast cancer
    Yang, Fang
    Zhang, Wenwen
    Shen, Yan
    Guan, Xiaoxiang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 927 - 932
  • [9] Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
    Zhou, Qin
    Xu, Jiawei
    Xu, Yan
    Sun, Shaokun
    Chen, Jian
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Potential Role of miRNA in Metastatic Cascade of Triple-Negative Breast Cancer
    Balkrishna, Acharya
    Mittal, Rashmi
    Arya, Vedpriya
    CURRENT CANCER DRUG TARGETS, 2021, 21 (02) : 153 - 162